Eton Pharmaceuticals Inc. (ETON)
NASDAQ: ETON
· Real-Time Price · USD
21.28
1.14 (5.66%)
At close: Sep 26, 2025, 3:21 PM
Eton Pharmaceuticals Revenue
Eton Pharmaceuticals reported an annual revenue of $39.01M, reflecting a 23.29% growth. For the quarter ending June 30, 2025, Eton Pharmaceuticals generated $18.93M in revenue.
Revenue (ttm)
39.01M
Revenue Growth
23.29%
Price / Sales Ratio
8.84
Revenue / Employee
1.26M
Employees
31
Market Cap
570.68M
Revenue Chart
History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2024 | 39.01M | +23.29% |
Dec 31, 2023 | 31.64M | +48.90% |
Dec 31, 2022 | 21.25M | -2.66% |
Dec 31, 2021 | 21.83M | +55879.49% |
Dec 31, 2020 | 39K | -95.93% |
Dec 31, 2019 | 959K | +Infinity% |
Dec 31, 2018 | 0 | n/a |
Dec 31, 2017 | 0 | n/a |